242 related articles for article (PubMed ID: 29772277)
1. Severity, therapeutic, and activity tear biomarkers in dry eye disease: An analysis from a phase III clinical trial.
Pinto-Fraga J; Enríquez-de-Salamanca A; Calonge M; González-García MJ; López-Miguel A; López-de la Rosa A; García-Vázquez C; Calder V; Stern ME; Fernández I
Ocul Surf; 2018 Jul; 16(3):368-376. PubMed ID: 29772277
[TBL] [Abstract][Full Text] [Related]
2. Topical fluorometholone treatment and desiccating stress change inflammatory protein expression in tears.
Nättinen J; Jylhä A; Aapola U; Enríquez-de-Salamanca A; Pinto-Fraga J; López-Miguel A; González-García MJ; Stern ME; Calonge M; Zhou L; Nykter M; Uusitalo H; Beuerman R
Ocul Surf; 2018 Jan; 16(1):84-92. PubMed ID: 28918083
[TBL] [Abstract][Full Text] [Related]
3. Topical Fluorometholone Protects the Ocular Surface of Dry Eye Patients from Desiccating Stress: A Randomized Controlled Clinical Trial.
Pinto-Fraga J; López-Miguel A; González-García MJ; Fernández I; López-de-la-Rosa A; Enríquez-de-Salamanca A; Stern ME; Calonge M
Ophthalmology; 2016 Jan; 123(1):141-53. PubMed ID: 26520171
[TBL] [Abstract][Full Text] [Related]
4. Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease.
Enríquez-de-Salamanca A; Castellanos E; Stern ME; Fernández I; Carreño E; García-Vázquez C; Herreras JM; Calonge M
Mol Vis; 2010 May; 16():862-73. PubMed ID: 20508732
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers in Ocular Chronic Graft Versus Host Disease: Tear Cytokine- and Chemokine-Based Predictive Model.
Cocho L; Fernández I; Calonge M; Martínez V; González-García MJ; Caballero D; López-Corral L; García-Vázquez C; Vázquez L; Stern ME; Enríquez-de-Salamanca A
Invest Ophthalmol Vis Sci; 2016 Feb; 57(2):746-58. PubMed ID: 26927568
[TBL] [Abstract][Full Text] [Related]
6. Study design and baseline findings from the progression of ocular findings (PROOF) natural history study of dry eye.
McDonnell PJ; Pflugfelder SC; Stern ME; Hardten DR; Conway T; Villanueva L; Hollander DA
BMC Ophthalmol; 2017 Dec; 17(1):265. PubMed ID: 29284427
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers of ocular allergy and dry eye disease.
Zemba M; Ionescu MA; Pîrvulescu RA; Dumitrescu OM; Daniel-Constantin B; Radu M; Stamate AC; Istrate S
Rom J Ophthalmol; 2023; 67(3):250-259. PubMed ID: 37876509
[TBL] [Abstract][Full Text] [Related]
8. Topical steroid and non-steroidal anti-inflammatory drugs inhibit inflammatory cytokine expression on the ocular surface in the botulinum toxin B-induced murine dry eye model.
Zhu L; Zhang C; Chuck RS
Mol Vis; 2012; 18():1803-12. PubMed ID: 22815633
[TBL] [Abstract][Full Text] [Related]
9. Response profiles to a controlled adverse desiccating environment based on clinical and tear molecule changes.
Fernández I; López-Miguel A; Enríquez-de-Salamanca A; Tesón M; Stern ME; González-García MJ; Calonge M
Ocul Surf; 2019 Jul; 17(3):502-515. PubMed ID: 30936038
[TBL] [Abstract][Full Text] [Related]
10. Association of Tear Cytokine Ratios with Symptoms and Signs of Dry Eye Disease: Biomarker Data from the Dry Eye Assessment and Management Study.
Zhao CS; Chen Y; Ying GS; Asbell PA;
Curr Eye Res; 2024 Jan; 49(1):16-24. PubMed ID: 37781912
[TBL] [Abstract][Full Text] [Related]
11. Immunomodulatory effect of the topical ophthalmic Janus kinase inhibitor tofacitinib (CP-690,550) in patients with dry eye disease.
Huang JF; Yafawi R; Zhang M; McDowell M; Rittenhouse KD; Sace F; Liew SH; Cooper SR; Pickering EH
Ophthalmology; 2012 Jul; 119(7):e43-50. PubMed ID: 22607938
[TBL] [Abstract][Full Text] [Related]
12. Correlations between tear cytokines, chemokines, and soluble receptors and clinical severity of dry eye disease.
Na KS; Mok JW; Kim JY; Rho CR; Joo CK
Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5443-50. PubMed ID: 22789923
[TBL] [Abstract][Full Text] [Related]
13. Tear Luminex Analysis in Dry Eye Patients.
Zhao H; Li Q; Ye M; Yu J
Med Sci Monit; 2018 Oct; 24():7595-7602. PubMed ID: 30356032
[TBL] [Abstract][Full Text] [Related]
14. Intra- and inter-day variation of cytokines and chemokines in tears of healthy subjects.
Benito MJ; González-García MJ; Tesón M; García N; Fernández I; Calonge M; Enríquez-de-Salamanca A
Exp Eye Res; 2014 Mar; 120():43-9. PubMed ID: 24412438
[TBL] [Abstract][Full Text] [Related]
15. sPLA
Wei Y; Asbell PA
Exp Eye Res; 2020 Dec; 201():108209. PubMed ID: 33011237
[TBL] [Abstract][Full Text] [Related]
16. Tear biomarkers in dry eye disease: Progress in the last decade.
Kumar NR; Praveen M; Narasimhan R; Khamar P; D'Souza S; Sinha-Roy A; Sethu S; Shetty R; Ghosh A
Indian J Ophthalmol; 2023 Apr; 71(4):1190-1202. PubMed ID: 37026250
[TBL] [Abstract][Full Text] [Related]
17. Tear Inflammatory Cytokines Analysis and Clinical Correlations in Diabetes and Nondiabetes With Dry Eye.
Liu R; Ma B; Gao Y; Ma B; Liu Y; Qi H
Am J Ophthalmol; 2019 Apr; 200():10-15. PubMed ID: 30552892
[TBL] [Abstract][Full Text] [Related]
18. Tear Interferon-Gamma as a Biomarker for Evaporative Dry Eye Disease.
Jackson DC; Zeng W; Wong CY; Mifsud EJ; Williamson NA; Ang CS; Vingrys AJ; Downie LE
Invest Ophthalmol Vis Sci; 2016 Sep; 57(11):4824-4830. PubMed ID: 27654409
[TBL] [Abstract][Full Text] [Related]
19. Cytokine and chemokine tear levels in patients with uveitis.
Carreño E; Portero A; Herreras JM; García-Vázquez C; Whitcup SM; Stern ME; Calonge M; Enríquez-de-Salamanca A
Acta Ophthalmol; 2017 Aug; 95(5):e405-e414. PubMed ID: 27873479
[TBL] [Abstract][Full Text] [Related]
20. Cytokine and Chemokine Concentration in the Tear of Patients with Age-Related Cataract.
Engelbrecht C; Sardinha LR; Rizzo LV
Curr Eye Res; 2020 Sep; 45(9):1101-1106. PubMed ID: 31928443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
